Photocure - Articles and news items


NICE publishes bladder cancer guideline, recommending photodynamic diagnosis to improve detection

Industry news / 2 March 2015 / Photocure ASA

Photocure ASA, a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, is pleased to announce that the National Institute for Health and Care Excellence (NICE) in the UK has published its first guidelines on bladder cancer, recommending photodynamic diagnosis for improved detection of bladder cancer…


Photocure announces end of Phase 2 status achieved for Cevira in U.S.

Industry news / 7 January 2015 / Photocure

Cevira advances towards Phase 3 for treatment in patients with cervical high grade lesions (HSIL)…


Photocure: Cevira® data published in American Journal of Obstetrics & Gynecology

Industry news / 4 November 2014 / Photocure

Phase 2b results demonstrate significant and sustained efficacy in treating human papilloma virus and precancerous lesions of the cervix…


Photocure: Expert consensus on the optimal use of Cysview® BLC published in Nature Reviews Urology

Industry news / 25 September 2014 / Photocure ASA

Cysview® improves detection of Non-Muscle Invasive Bladder Cancer (NMIBC) beyond that achieved with current standard of care…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...